Oliver Bechter

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Topics

Transforming Growth Factor

Metastatic Renal Cell Carcinoma

Top Venues

Clinical and translational science

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Debbie Robbrecht, Jean-Jacques Grob, Oliver Bechter, Matteo Simonelli, Bernard Doger, Ivan Borbath, Marcus O Butler, Tina Cheng, Patricia Martin Romano, Elvire Pons-Tostivint, Massimo Di Nicola, Giuseppe Curigliano, Min-Hee Ryu, Alejo Rodriguez-Vida, Dirk Schadendorf, Elena Garralda, Giovanni Abbadessa, Brigitte Demers, Amele Amrate, Hong Wang, Joon Sang Lee, Robert Pomponio, Rui Wang
Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors. Clinical and translational science 17 (2) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Joaquina C Baranda, Debbie Robbrecht, Ryan Sullivan, Bernard Doger, Armando Santoro, Minal Barve, Jean-Jacques Grob, Oliver Bechter, Maria Vieito, Maria Jose de Miguel, Dirk Schadendorf, Melissa Johnson, Clemence Pouzin, Cathy Cantalloube, Rui Wang, Jooyun Lee, Xiaofei Chen, Brigitte Demers, Amele Amrate, Giovanni Abbadessa, F Stephen Hodi
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study. Clinical and translational science 17 (6) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Debbie Robbrecht, Jean-Jacques Grob, Oliver Bechter, Matteo Simonelli, Bernard Doger, Ivan Borbath, Marcus O Butler, Tina Cheng, Patricia Martin Romano, Elvire Pons-Tostivint, Massimo Di Nicola, Giuseppe Curigliano, Min-Hee Ryu, Alejo Rodriguez-Vida, Dirk Schadendorf, Elena Garralda, Giovanni Abbadessa, Brigitte Demers, Amele Amrate, Hong Wang, Joon Sang Lee, Robert Pomponio, Rui Wang
Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors. Clinical and translational science 17 (2) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Joaquina C Baranda, Debbie Robbrecht, Ryan Sullivan, Bernard Doger, Armando Santoro, Minal Barve, Jean-Jacques Grob, Oliver Bechter, Maria Vieito, Maria Jose de Miguel, Dirk Schadendorf, Melissa Johnson, Clemence Pouzin, Cathy Cantalloube, Rui Wang, Jooyun Lee, Xiaofei Chen, Brigitte Demers, Amele Amrate, Giovanni Abbadessa, F Stephen Hodi
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study. Clinical and translational science 17 (6) (2024)
Debbie Robbrecht, Jean-Jacques Grob, Oliver Bechter, Matteo Simonelli, Bernard Doger, Ivan Borbath, Marcus O Butler, Tina Cheng, Patricia Martin Romano, Elvire Pons-Tostivint, Massimo Di Nicola, Giuseppe Curigliano, Min-Hee Ryu, Alejo Rodriguez-Vida, Dirk Schadendorf, Elena Garralda, Giovanni Abbadessa, Brigitte Demers, Amele Amrate, Hong Wang, Joon Sang Lee, Robert Pomponio, Rui Wang
Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors. Clinical and translational science 17 (2) (2024)
Joaquina C Baranda, Debbie Robbrecht, Ryan Sullivan, Bernard Doger, Armando Santoro, Minal Barve, Jean-Jacques Grob, Oliver Bechter, Maria Vieito, Maria Jose de Miguel, Dirk Schadendorf, Melissa Johnson, Clemence Pouzin, Cathy Cantalloube, Rui Wang, Jooyun Lee, Xiaofei Chen, Brigitte Demers, Amele Amrate, Giovanni Abbadessa, F Stephen Hodi
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study. Clinical and translational science 17 (6) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Joaquina C Baranda, Debbie Robbrecht, Ryan Sullivan, Bernard Doger, Armando Santoro, Minal Barve, Jean-Jacques Grob, Oliver Bechter, Maria Vieito, Maria Jose de Miguel, Dirk Schadendorf, Melissa Johnson, Clemence Pouzin, Cathy Cantalloube, Rui Wang, Jooyun Lee, Xiaofei Chen, Brigitte Demers, Amele Amrate, Giovanni Abbadessa, F Stephen Hodi
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study. Clinical and translational science 17 (6) (2024)
Lize Vanaken, F J S H Sherida Woei-A-Jin, Rita Van Ginderdeuren, Christophe M Deroose, Annouschka Laenen, Guy Missotten, Dietmar Rudolf Thal, Oliver Bechter, Patrick Schöffski, Paul Clement
Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study. Acta oncologica (Stockholm, Sweden) (2023)
Jelle Verhoeven, Kathryn A Jacobs, Francesca Rizzollo, Francesca Lodi, Yichao Hua, Joanna Poźniak, Adhithya Narayanan Srinivasan, Diede Houbaert, Gautam Shankar, Sanket More, Marco B Schaaf, Nikolina Dubroja Lakic, Maarten Ganne, Jochen Lamote, Johan Van Weyenbergh, Louis Boon, Oliver Bechter, Francesca Bosisio, Yasuo Uchiyama, Mathieu Jm Bertrand, Jean Christophe Marine, Diether Lambrechts, Gabriele Bergers, Madhur Agrawal, Patrizia Agostinis
Tumor endothelial cell autophagy is a key vascular-immune checkpoint in melanoma. EMBO molecular medicine (2023)
Stefan Naulaerts, Angeliki Datsi, Daniel M Borras, Asier Antoranz, Julie Messiaen, Isaure Vanmeerbeek, Jenny Sprooten, Raquel S Laureano, Jannes Govaerts, Dena Panovska, Marleen Derweduwe, Michael C Sabel, Marion Rapp, Weiming Ni, Sean Mackay, Yannick Van Herck, Lendert Gelens, Tom Venken, Sanket More, Oliver Bechter, Gabriele Bergers, Adrian Liston, Steven De Vleeschouwer, Benoit J Van den Eynde, Diether Lambrechts, Michiel Verfaillie, Francesca Maria Bosisio, Sabine Tejpar, Jannie Borst, Rüdiger V Sorg, Frederik De Smet, Abhishek Dinkarnath Garg
Multiomics and spatial mapping characterizes human CD8 + T cell states in cancer. Science translational medicine 15 (691) (2023)
Steven M Horwitz, Julia J Scarisbrick, Reinhard Dummer, Sean Whittaker, Madeleine Duvic, Youn H Kim, Pietro Quaglino, Pier Luigi Luigi Zinzani, Oliver Bechter, Herbert Eradat, Lauren Pinter-Brown, Oleg E Akilov, Larisa Geskin, Jose Antonio Sanches, Pablo Luis Ortiz-Romero, Michael Weichenthal, David C Fisher, Jan Walewski, Judith Trotman, Kerry Taylor, Stephane Dalle, Rudolf Stadler, Julie Lisano, Veronica Bunn, Meredith Little, Henry Miles Prince
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data. Blood advances 5 (23) (2022)
Asier Antoranz, Yannick Van Herck, Maddalena Maria Bolognesi, Seodhna M Lynch, Arman Rahman, William M Gallagher, Veerle Boecxstaens, Jean-Christophe Marine, Giorgio Cattoretti, Joost J van den Oord, Frederik De Smet, Oliver Bechter, Francesca Maria Bosisio
Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell-Cell Interactions That Predict Immunotherapy Response. Cancer research 82 (18) (2022)
Panagiotis Karras, Ignacio Bordeu, Joanna Pozniak, Ada Nowosad, Cecilia Pazzi, Nina Van Raemdonck, Ewout Landeloos, Yannick Van Herck, Dennis Pedri, Greet Bervoets, Samira Makhzami, Jia Hui Khoo, Benjamin Pavie, Jochen Lamote, Oskar Marin-Bejar, Michael Dewaele, Han Liang, Xingju Zhang, Yichao Hua, Jasper Wouters, Robin Browaeys, Gabriele Bergers, Yvan Saeys, Francesca Maria Bosisio, Joost van den Oord, Diether Lambrechts, Anil K Rustgi, Oliver Bechter, Cédric Blanpain, Benjamin David Simons, Florian Rambow, Jean-Christophe Marine
A cellular hierarchy in melanoma uncouples growth and metastasis. Nature 610 (7930) (2022)
Dorien Laenens, Yu-Ling Yu, Beatrice Santens, Johanna E J Jacobs, Benoit Beuselinck, Oliver Bechter, Els Wauters, Jan A Staessen, Stefan Janssens, Lucas N L Van Aelst
Incidence of Cardiovascular Events in Patients Treated With Immune Checkpoint Inhibitors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Canan Güvenç, Asier Antoranz, Anna Szumera-Ciećkiewicz, Pawel P Teterycz, Piotr Lukasz Rutkowski, Robert V Rawson, Richard A Scolyer, John F Thompson, Julia Newton-Bishop, Marguerite Stas, Veerle Boecxstaens, Oliver Bechter, Jurgen Vercauteren, Marjan Garmyn, Joost van den Oord, Francesca Maria Bosisio
Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas. International journal of molecular sciences 22 (19) (2021)
Ward Celus, Ana I Oliveira, Silvia Rivis, Heleen H Van Acker, Ewout Landeloos, Jens Serneels, Sarah Trusso Cafarello, Yannick Van Herck, Roberta Mastrantonio, Arnaud Köhler, Abhishek Dinkarnath Garg, Véronique Flamand, Luca Tamagnone, Jean-Christophe Marine, Mario Di Matteo, Bruno M Costa, Oliver Bechter, Massimiliano Mazzone
PlexinA4 mediates cytotoxic T cell trafficking and exclusion in cancer. Cancer immunology research (2021)
Roberto Vendramin, Vasiliki Katopodi, Sonia Cinque, Angelina Konnova, Zorica Knezevic, Sara Adnane, Yvessa Verheyden, Panagiotis Karras, Ewout Demesmaeker, Francesca Maria Bosisio, Lukas Kucera, Jan Rozman, Ivan Gladwyn-Ng, Lara Rizzotto, Erik Dassi, Stefania Millevoi, Oliver Bechter, Jean-Christophe Marine, Eleonora Leucci
Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma. The Journal of experimental medicine 218 (9) (2021)
Greet Van De Sijpe, Benoit Beuselinck, Tine Van Nieuwenhuyse, Roxanne Poncelet, Oliver Bechter, Maarten Albersen, Eduard Roussel, Marcella Baldewijns, Tack Jan, Isabel Spriet
Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma. European journal of clinical pharmacology 76 (9) (2020)